Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease

Journal of Infectious Diseases

Volumn 170, Issue 3, 1994, Pages 585-591

  Norrby Teglund, Anna ^a   Pauksens, Karlis ^a   Holm, Stig E ^a   Norgren, Mari ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EXOTOXIN; MITOGENIC AGENT; NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; BACTEREMIA; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MITOGENICITY; MONONUCLEAR CELL; PRIORITY JOURNAL; SEROCONVERSION; STREPTOCOCCUS INFECTION; TONSILLITIS;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOTOXINS; FEMALE; HUMAN; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; NEUTRALIZATION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; REFERENCE VALUES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPPORT, NON-U.S. GOV'T;

EID: 0028021477     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/170.3.585     Document Type: Article

References (40)

1. Barsumian BL, Cunningham CM, Schiievert PM, Watson DW. Hetero geneity of group A streptococcal pyrogenic exotoxin type B. Infect Immun 1978;20:512-8.
2. Cunningham CM, Barsumian BL, Watson DW. Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin. Infect Immun 1976;14:767-75.
3. Schiievert PM, Bettin KM, Watson DW. Purification and characterization of group A streptococcal pyrogenic exotoxin C. Infect immun 1977;16:673-9.
4. Cone LA, Voodard DR, Schiievert PM, Tomory GS. Clinical and bactériologie observation of a toxic shock-like syndrome due to Streptococcus pyogenes.New Engl J Med 1987;317:146-9.
5. Hauser AR, Stevens DL, Kaplan EL, Schiievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 1991;29:1562-7.
6. Holm SE, Norrby A, Bergholm AM, Norgren M. Aspects of pathogenesis in serious group A streptococcal infections in Sweden, 1988— 1989. J Infect Dis 1992;166:31-7.
7. Musser JM, Hauser AR, Kim MH, Schiievert PM, Nelson K, Selander RK. Streptococcus pyogenes causing toxic shock-like syndrome and other invasive disease: Clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 1991;88:2668-72.
8. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1-7.
9. Kim YB, Watson DW. Streptococcal exotoxins: Biological and pathological properties. In: Wannamaker LW, Matsen JM, eds. Streptococci and streptococcal diseases. Recognition, understanding and management. New York: Academic Press, 1972:33-50.
10. Wannamaker LW, Schlievert PM. Exotoxins of group A streptococci. In: Hardegree MC. Tu AT, eds. Bacterial toxins. New York: Marcel Dekker. 1988:267-96.
11. Alouf JE, Knoll H, Kohler W. The family of mitogenic, shock-inducing and superantigenic toxins from staphylococci and streptococci. In: Alouf JE, Freer JH, eds. Sourcebook of bacterial toxins. San Diego: Academic Press, 1991:367-414.
12. Kotb M. Role of superantigens in the pathogenesis of infectious diseases and their sequelae. Curr Opin Infect Dis 1992;5:364-74.
13. Marrack P. Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;278:705-11.
14. lwasaki M, Igarashi H, Hinuma Y, Yutsudo T. Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor. FEBS Lett 1993;331:187-92.
15. Mollick J A, Miller GG, Musser JM, Cook RG, Grossman D, Rich RR. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest 1993;92:710-9.
16. Norrby-Teglund A, Norgren M, Holm SE, Andersson U, Andersson J. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and the pyrogenic exotoxins A and B. Infect Immun 1994 (in press).
17. Mollick JA, Cook RG, Rich RR. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. Science 1989:244:817-20.
18. Scholl P, Diez A, Mourad N, Parsonnet J, Geha RS, C'hatila T. Toxic shock syndrome toxin I binds to major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 1989;86:4210-4.
19. Uchiyama T, Imanishi K, Saito S, et al. Activation of human T cells by toxic shock syndrome toxin-1: The toxin binding structures expressed on human lymphoid cells acting as accessory cells are HI.A class II molecules. Eur J Immunol 1989;19:1803-9.
20. Uchiyama T, Takamuda T, Imanishi K, et al. Activation of murine T cells by toxic shock syndrome toxin-1: The toxin binding structures expressed on murine accessory cells are MHC class II molecules. J Immunol 1989;143:3175-82.
21. Fleicher B, Schrezenmeizer M, Conradt P. T lymphocyte activation by staphylococcal enterotoxins, role of class II molecules and T cell surface structures. Cell Immunol 1989;120:92-101.
22. Fleicher B, Gerardy-Schan R. Metzroth B. Carrel S, Gerlach D, Kohler W. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction. J Immunol 1991:146:11-7.
23. Janeway CA. Yagi J Jr. Conrad P.I, Katz ME, Jones B, Vroegop S, Buxser S. T cell responses to Mis and to bacterial proteins that mimic its behavior. Immunol Rev 1989;107:61-88.
24. Kotb M, Watanahe-Ohnishi R, Wang B, et al. Analysis of the TCR Vflspecificities of bacterial superantigens using PCR. Immunomethods 1993:33:33-40.
25. Andersson J, Nagy S. Bjork L, Abrams J. Holm S, Andersson U. Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol Rev 1992;127:67-96.
26. Hackett SP, Stevens DL. Streptococcal toxic shock syndrome: Synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic cxotoxin A and streptolysin O. J Infect Dis 1992;165:879-85.
27. Hackett SP. Stevens DL. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-jS synthesis. J Infect Dis 1993;168:232-5.
28. Jupin C. Andersson S, Damais C, Alouf JE, Parant M. Toxic shock syndrome toxin I as inducer of human tumor necrosis factor and 7-interferon. J Exp Med 1988;167:752-61.
29. Uchiyama T, Kamagata Y, Yan XJ, et al. Study on the biological activi ties of toxic shock syndrome toxin-1. II. Induction of the proliferative response and the interleukin-2 production by T-cells from human peripheral blood mononuclear cells stimulated with the toxin. Clin Exp Immunol 1987;68:638-47.
30. Gaworzewska E, Colman G. Changes in the pattern of infection caused by Streptococcus pyogenes.Epidemiol Infect 1988;100:257-69.
31. Martin PR, Hoiby EA. Streptococcal serogroup A epidemic in Norway 1987-88. Scand J Infect Dis 1990;22:421-9.
32. Strömberg A, Romanus V, Burman LG. Outbreak of group A strepto coccal bacteremia in Sweden: An epidemiologic and clinical study. J Infect Dis 1991;164:595-8.
33. Norgren M, Norrby A, Holm SE. Genetic diversity in TIM1 group A streptococci in relation to the clinical outcome of the infection. J Infect Dis 1992;166:1014-20.
34. Knöll H, Holm SE, Gerlach D, KuhnemundO. Köhler W. Tissue cages for study of experimental streptococcal infection in rabbits. II. Humoral and cell mediated immune response to erythrogenic toxins. Immunobiology 1985; 169:1 16-27.
35. Gerlach D, Kohler W. Isolierung und Characterisierung von Erythro-genen Toxinen. I. Untersuchung des von Streptococcus pyogenes Stamm NY 5, Gebildeten toxin A. Zcntralhl Bakteriol Hyg I Abt Orig A 1980;247:177-91.
36. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-69.
37. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968;2I (suppl):77-89.
38. Abe Y, Nakano S, Nakahara T, et al. Detection of serum antibody by the antimitogen assay against streptococcal erythrogenic toxins. Age distribution in children and the relation to Kawasaki disease. Pediatr Res 1990;7:11-5.
39. Rosenberg WMC, Moss PAH, Bell JI. Variation in human T cell receptor Vd and.l/t repertoire: Analysis using anchor polymerase chain reaction. Eur J Immunol 1992;22:541-9.
40. Malhotra U, Spielman R, C'oncannon P. Variability in T cell receptor Vß gene usage in human peripheral blood lymphocytes. Studies in identical twins, siblings, and insulin-dependent diabetes mellitus patients. J Immunol 1992;149:1802-8.